StockTipsArenaBeta

BUY Piramal Pharma Limited — Kunal Hasmukhlal Shah

BUYPiramal Pharma Limited
Piramal Pharma share price target & all analyst calls

byKunal Hasmukhlal ShahHorizon: NA (inferred Intraday)2 Sept 2026, 1:52 pm ISTvia Zee Business (Live)

Entry₹217.25Inferred
Target₹222
Total upside +2.19% (call closed)
Stop loss₹212-2.42% risk
At expiry₹213.982 Sept 2026, 3:20 pm
Expired-1.51%
Follow Kunal Hasmukhlal Shah for new calls(21% target hit, 34 closed calls)Get alertsWatch PPLPHARMA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 2 Sept 2026
2 supporting2 neutral0 opposing
Supports the BUY call (2)

Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations

NewsGoogle News·26 Aug · 6d ago

(opens in new tab)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·27 Aug · 6d ago

Neutral / worth noting (2)

US envoy Sergio Gor meets Piramal Group Chairman Ajay Piramal, discusses expansion plans in US

NewsGoogle News·27 Aug · 5d ago

(opens in new tab)

US envoy Sergio Gor meets Piramal Group Chairman Ajay Piramal, discusses expansion plans in US

NewsGoogle News·27 Aug · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Piramal Pharma

All analyst calls on Piramal Pharma

More from Kunal Hasmukhlal Shah

Every call and its outcome